![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig1_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial | Request PDF Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial | Request PDF](https://i1.rgstatic.net/publication/362480566_Baseline_characteristics_of_adults_with_neurofibromatosis_enrolled_on_a_psychosocial_randomized_controlled_trial/links/62ec7b9b88b83e7320ac4300/largepreview.png)
Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial | Request PDF
![Neurofibromatosis (NF) Center provides patient care and support, seeks solutions – Washington University School of Medicine in St. Louis Neurofibromatosis (NF) Center provides patient care and support, seeks solutions – Washington University School of Medicine in St. Louis](https://medicine.wustl.edu/wp-content/uploads/NF2-meningiomas.jpg)
Neurofibromatosis (NF) Center provides patient care and support, seeks solutions – Washington University School of Medicine in St. Louis
![Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation | Genetics in Medicine Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation | Genetics in Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41436-021-01170-5/MediaObjects/41436_2021_1170_Figa_HTML.png)